Matches in Wikidata for { <http://www.wikidata.org/entity/Q81690870> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q81690870 description "artículu científicu espublizáu n'agostu de 2008" @default.
- Q81690870 description "im August 2008 veröffentlichter wissenschaftlicher Artikel" @default.
- Q81690870 description "scientific article published on 01 August 2008" @default.
- Q81690870 description "wetenschappelijk artikel" @default.
- Q81690870 description "наукова стаття, опублікована в серпні 2008" @default.
- Q81690870 name "Caution on the interpretation of plasma fatty acid composition as a proxy marker for SCD1 activity: particular implications for using the 16:1/16:0 ratio in QTL studies involving hyperlipidemic patients" @default.
- Q81690870 name "Caution on the interpretation of plasma fatty acid composition as a proxy marker for SCD1 activity: particular implications for using the 16:1/16:0 ratio in QTL studies involving hyperlipidemic patients" @default.
- Q81690870 type Item @default.
- Q81690870 label "Caution on the interpretation of plasma fatty acid composition as a proxy marker for SCD1 activity: particular implications for using the 16:1/16:0 ratio in QTL studies involving hyperlipidemic patients" @default.
- Q81690870 label "Caution on the interpretation of plasma fatty acid composition as a proxy marker for SCD1 activity: particular implications for using the 16:1/16:0 ratio in QTL studies involving hyperlipidemic patients" @default.
- Q81690870 prefLabel "Caution on the interpretation of plasma fatty acid composition as a proxy marker for SCD1 activity: particular implications for using the 16:1/16:0 ratio in QTL studies involving hyperlipidemic patients" @default.
- Q81690870 prefLabel "Caution on the interpretation of plasma fatty acid composition as a proxy marker for SCD1 activity: particular implications for using the 16:1/16:0 ratio in QTL studies involving hyperlipidemic patients" @default.
- Q81690870 P1433 Q81690870-3075E97F-F907-4E73-8FC3-702B8142AD96 @default.
- Q81690870 P1476 Q81690870-E84C3EC3-0B39-4CF1-BA9A-868A780E7B34 @default.
- Q81690870 P2093 Q81690870-2A5AF58B-5219-4B84-933C-0CFC19BE5258 @default.
- Q81690870 P2093 Q81690870-366AF9E0-483A-4E66-89B8-1B764B473C0A @default.
- Q81690870 P304 Q81690870-96993D99-B961-47A1-AF9E-365486484BCE @default.
- Q81690870 P31 Q81690870-D9A84B66-3A11-4B6F-87BF-B67AB6D09442 @default.
- Q81690870 P356 Q81690870-90BB1B35-8F92-4C93-AC20-27DB30ECBFB5 @default.
- Q81690870 P433 Q81690870-69CE3912-5CC2-4AEF-87C8-62E865C1FEC3 @default.
- Q81690870 P478 Q81690870-588DC898-636F-48FE-A30D-94F66565BF7F @default.
- Q81690870 P577 Q81690870-57C97928-A5BC-449F-8651-9AF9F778FD40 @default.
- Q81690870 P698 Q81690870-70844500-CC0C-427A-AB32-5DCB9D87C891 @default.
- Q81690870 P356 ATVBAHA.108.167718 @default.
- Q81690870 P698 18650501 @default.
- Q81690870 P1433 Q4797542 @default.
- Q81690870 P1476 "Caution on the interpretation of plasma fatty acid composition as a proxy marker for SCD1 activity: particular implications for using the 16:1/16:0 ratio in QTL studies involving hyperlipidemic patients" @default.
- Q81690870 P2093 "Fredrik Karpe" @default.
- Q81690870 P2093 "Leanne Hodson" @default.
- Q81690870 P304 "e152; author reply e153" @default.
- Q81690870 P31 Q13442814 @default.
- Q81690870 P356 "10.1161/ATVBAHA.108.167718" @default.
- Q81690870 P433 "8" @default.
- Q81690870 P478 "28" @default.
- Q81690870 P577 "2008-08-01T00:00:00Z" @default.
- Q81690870 P698 "18650501" @default.